Trial: Evaluation of the effectiveness of two antiretroviral treatment strategies to prevent HIV transmission in HIV-serodiscordant couples [HPTN 052]
Phase: III
Product Being Tested: Highly active antiretroviral therapy for HIV prevention
Sponsor, funder, developer, collaborator:HIV Prevention Trials Network, Gaborone Prevention/Treatment Trials CRS
Total participants: 1,750 couples
Countries: Botswana, Brazil, India, Kenya, Malawi, South Africa, Thailand, Zimbabwe
Trial sites in Kenya: Kisumu
Results expected: n/a
For more information: http://www.hptn.org/research_studies/hptn052.asp


Trial: Safety and acceptability trial of dapivirine gel, conducted using daily monitored adherence in healthy HIV-negative women [IPM014A/B]
Phase: I/II
Product Being Tested: Dapivirine gel
Sponsor, funder, developer, collaborator: International Partnership for Microbicides, Kenya Medical Research Institute
Total participants: 320
Countries: Kenya, Malawi, Rwanda, South Africa, Tanzania
Trial sites in Kenya: Kisumu
Results expected: July 2012
For more information: http://clinicaltrials.gov/ct2/show/NCT00917904?term=IPM014B&rank=1
Back to Top ↑